Perspectives on Brain-Targeting Drug Delivery Systems

被引:45
作者
Guo, Liangran
Ren, Jinfeng
Jiang, Xinguo [1 ]
机构
[1] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
关键词
Blood-brain barrier; brain-targeting drug delivery systems; receptor-mediated transcytosis; adsorptive-mediated transcytosis; transporter-mediated transcytosis; nose-to-brain; chemical delivery systems; prodrugs; CONJUGATED PEGYLATED NANOPARTICLES; CARRIER-MEDIATED TRANSPORT; CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-A-I; GENE DELIVERY; BRADYKININ AGONIST; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; BLOOD; BARRIER;
D O I
10.2174/138920112803341770
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to the presence of the blood-brain barrier, there is limited drug access into the brain. In order to overcome this challenge, various strategies have been developed to enhance penetration of drugs into the brain. Of these, the most frequently used are pharmacological technologies or comparable methods being developed for brain-targeting drug delivery using receptor- or adsorptive- or transporter-mediated transcytosis and the nose-to-brain route. It goes without saying that exploration of Brain-targeting drug delivery systems has created another potential option for the treatment of central nervous system diseases. In addition to above methods, other technologies for brain-targeting drug delivery (e.g. chemical delivery systems, prodrugs, pharmacological disruption of the BBB and inhibition of drug efflux by P-glycoprotein) are also summaried in this review.
引用
收藏
页码:2310 / 2318
页数:9
相关论文
共 97 条
[1]   Single domain antibodies as blood-brain barrier delivery vectors [J].
Abulrob, A ;
Zhang, JB ;
Tanha, J ;
MacKenzie, R ;
Stanimirovic, D .
DRUG TRANSPORT(ERS) AND THE DISEASED BRAIN, 2005, 1277 :212-223
[2]   The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells [J].
Abulrob, A ;
Sprong, H ;
Henegouwen, PVBE ;
Stanimirovic, D .
JOURNAL OF NEUROCHEMISTRY, 2005, 95 (04) :1201-1214
[3]   Prodrugs for improved CNS delivery [J].
Anderson, BD .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (02) :171-202
[4]   Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated system [J].
Bartus, RT ;
Elliott, P ;
Hayward, N ;
Dean, R ;
McEwen, EL ;
Fisher, SK .
IMMUNOPHARMACOLOGY, 1996, 33 (1-3) :270-278
[5]   Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7 [J].
Bartus, RT ;
Elliott, PJ ;
Dean, RL ;
Hayward, NJ ;
Nagle, TL ;
Huff, MR ;
Snodgrass, PA ;
Blunt, DG .
EXPERIMENTAL NEUROLOGY, 1996, 142 (01) :14-28
[6]   Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents [J].
Battaglia, G ;
La Russa, M ;
Bruno, V ;
Arenare, L ;
Ippolito, R ;
Copani, A ;
Bonina, F ;
Nicoletti, F .
BRAIN RESEARCH, 2000, 860 (1-2) :149-156
[7]   Brain targeting using novel lipid nanovectors [J].
Beduneau, Arnaud ;
Hindre, Francois ;
Clavreul, Anne ;
Leroux, Jean-Christophe ;
Saulnier, Patrick ;
Benoit, Jean-Pierre .
JOURNAL OF CONTROLLED RELEASE, 2008, 126 (01) :44-49
[8]   Active targeting of brain tumors using nanocarriers [J].
Beduneau, Arnaud ;
Saulnier, Patrick ;
Benoit, Jean-Pierre .
BIOMATERIALS, 2007, 28 (33) :4947-4967
[9]   Recent advances in blood-brain barrier disruption as a CNS delivery strategy [J].
Bellavance, Marc-Andre ;
Blanchette, Marie ;
Fortin, David .
AAPS JOURNAL, 2008, 10 (01) :166-177
[10]   Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease [J].
Bodor, N ;
Buchwald, P .
DRUG DISCOVERY TODAY, 2002, 7 (14) :766-774